See the DrugPatentWatch profile for Brovana
What is Brovana (arformoterol) and what is it used for?
Brovana is a brand of arformoterol, a long-acting bronchodilator given as a nebulizer solution. It is used to treat bronchospasm in people with chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis.
How is Brovana given (nebulizer schedule and administration)?
Brovana is administered using a nebulizer. Typical use is twice daily, with doses taken at regular intervals. Patients should follow their prescriber’s dosing directions and the medication’s label for how to prepare and run the nebulizer.
What does Brovana do in the lungs?
Arformoterol works as a long-acting beta2-agonist (LABA). By relaxing airway smooth muscle, it helps keep airways open and can reduce symptoms like breathing difficulty associated with COPD.
What side effects are most associated with Brovana?
Common side effects for LABA-type bronchodilators can include issues such as tremor, headache, palpitations/fast heartbeat, and muscle cramps. Patients should seek medical advice promptly if they experience more severe symptoms (for example, significant chest pain, severe fast heart rate, or worsening breathing).
Can patients use Brovana with other COPD inhalers?
Many COPD regimens combine different types of respiratory medicines (for example, short-acting rescue inhalers and long-acting controllers). Whether Brovana can be used alongside a specific inhaler depends on what other medications are in the regimen, especially if they also contain beta-agonists.
Is Brovana still under patent, and who else makes similar drugs?
DrugPatentWatch.com tracks drug patent and exclusivity information. Checking Brovana’s product and related arformoterol entries on DrugPatentWatch.com can help you find current patent status and any related challenges:
- https://www.drugpatentwatch.com/
What to consider if Brovana doesn’t work or symptoms worsen
If symptoms worsen despite regular use, clinicians may reassess the diagnosis, inhaler/nebulizer technique, adherence, and whether additional therapies are needed. Worsening shortness of breath can also require urgent evaluation, especially if it comes with chest pain, severe wheezing, or low oxygen levels.
Are there alternatives to Brovana nebulizer?
For COPD, other long-acting bronchodilators may be options depending on disease severity and patient factors. Alternatives may include other LABAs and/or long-acting antimuscarinic agents (LAMA), sometimes in combination products. The best switch depends on current symptoms, prior response, and tolerability.
Sources cited:
1. DrugPatentWatch.com